Companies / Black Diamond Therapeutics, Inc. / Activity
Activity — Black Diamond Therapeutics, Inc.
8 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q1 2021 as of | Leonteq Securities AG 13F manager | New | Common Stock | $6.1K | +250 | 250 <0.01% of shares | low |
| Q3 2021 as of | Leonteq Securities AG 13F manager | New | Common Stock | $8.5K | +1K | 1,000 <0.01% of shares | low |
| Q1 2026 as of | Prelude Capital Management, LLC 13F manager | New | Common Stock | $29.6K | +14K | 13,895 0.02% of shares | low |
| Q2 2026 as of | Deutsche Bank AG 13F manager | New | Common Stock | $85.2K | +46K | 46,038 0.08% of shares | low |
| Q1 2026 as of | Two Sigma Investments, LP 13F manager | New | Common Stock | $92.2K | +43K | 43,300 0.08% of shares | low |
| Q2 2026 as of | Quadrature Capital Ltd 13F manager | New | Common Stock | $141.9K | +77K | 76,706 0.13% of shares | low |
| Q4 2025 as of | Oxford Asset Management LLP 13F manager | New | Common Stock | $278.0K | +114K | 114,383 0.20% of shares | low |
| Q1 2026 as of | Balyasny Asset Management L.P. 13F manager | New | Common Stock | $1.09M | +511K | 510,811 0.89% of shares | low |